Patent ID: 8299095

Claim:
Compound I, which is 4-[2-(4-methylphenyl-sulfanyl)phenyl]piperidine and pharmaceutically acceptable salts thereof in a crystalline form selected from the group consisting of an: HBr addition salt in a crystalline form characterized by peaks in an XRPD at 6.08, 14.81, 19.26 and 25.38+/−0.10° 2θ; DL-lactic acid addition salt in a crystalline form characterized by peaks in an XRPD at 5.30, 8.18, 9.44 and 17.24+/−0.10° 2θ; glutaric acid addition salt (1:1) in a crystalline form characterized by peaks in an XRPD at 9.39, 11.70, 14.05 and 14.58+/−0.10° 2θ; and glutamic acid addition salt (1:1) in a crystalline form characterized by peaks in an XRPD at 7.71, 14.01, 19.26 and 22.57+/−0.10° 2θ.